Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.iPierian, a US based discoverer of effective therapeutics for patients, has named Nancy Stagliano as the new CEO.
Subscribe to our email newsletter
Stagliano, recently served as the CEO and co-founder of CytomX Therapeutics, will succeed interim CEO Peter Van Vlasselear.
Earlier, she worked as the COO of CytomX, which launched CytomX Therapeutics as well as Cynvenio Biosystems.
Prior to that Stagliano served for eight years at Millennium Pharmaceuticals and consulted to several local startups.